Optimizing the "Drug-like" Properties of Leads in Drug Discovery
Borchardt, Ronald T. (EDT); Kerns, Edward H. (EDT); Hageman, Michael J. (EDT); Thakker, Dhiren R. (EDT); Stevens, James L. (EDT)
ISBN 10: 0387340564 ISBN 13: 9780387340562
Editorial: Springer, 2006
Usado
Encuadernación de tapa dura
Librería:
GreatBookPrices, Columbia, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Vendedor de AbeBooks desde 6 de abril de 2009
Este artículo en concreto ya no está disponible.
Descripción
Descripción:
Unread book in perfect condition. N° de ref. del artículo 5973388
Sinopsis:
This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled "Optimizing the Drug-Like Properties of Leads in Drug Discovery," which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. The volume outlines strategies and methodologies designed to guide pharmaceutical and biotechnology companies through the drug discovery and development process.
Reseña del editor:
This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled "Optimizing the Drug-Like Properties of Leads in Drug Discovery," which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. The volume outlines strategies and methodologies designed to guide pharmaceutical and biotechnology companies through the drug discovery and development process.
"Sobre este título" puede pertenecer a otra edición de este libro.
Detalles bibliográficos
Título: Optimizing the "Drug-like" Properties of ...
Editorial: Springer
Año de publicación: 2006
Encuadernación: Encuadernación de tapa dura
Condición: As New
Los mejores resultados en AbeBooks
Imagen de archivo
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects, IV)
Publicado por
Springer (edition 2006), 2006
ISBN 10: 0387340564
ISBN 13: 9780387340562
Antiguo o usado
Tapa dura
Librería: BooksRun, Philadelphia, PA, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: Good. 2006. It's a preowned item in good condition and includes all the pages. It may have some general signs of wear and tear, such as markings, highlighting, slight damage to the cover, minimal wear to the binding, etc., but they will not affect the overall reading experience. Nº de ref. del artículo: 0387340564-11-1
Cantidad disponible: 1 disponibles
Imagen de archivo
Optimizing the Drug-Like Properties of Leads in Drug Discovery [With CDROM]
Librería: ThriftBooks-Dallas, Dallas, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less. Nº de ref. del artículo: G0387340564I3N00
Cantidad disponible: 1 disponibles
Imagen del vendedor
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects, IV)
Librería: ebooks Keystone, Reading, PA, Estados Unidos de America
Calificación del vendedor: 4 de 5 estrellas
Condición: good. This book is in good condition, with minimal signs of wear and tear. Nº de ref. del artículo: GWKV.0387340564.G
Cantidad disponible: 1 disponibles
Imagen de archivo
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects, IV)
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: ABLIING23Feb2215580172017
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
"Optimizing the \"Drug-Like\" Properties of Leads in Drug Discovery"
Publicado por
Springer New York, Springer New York Aug 2006, 2006
ISBN 10: 0387340564
ISBN 13: 9780387340562
Nuevo
Tapa dura
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Neuware -Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, ¿drug-like¿ properties refer to the molecule¿s physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 524 pp. Englisch. Nº de ref. del artículo: 9780387340562
Gastos de envío:
EUR 60,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 2 disponibles
Imagen del vendedor
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery
Publicado por
Springer New York Aug 2006, 2006
ISBN 10: 0387340564
ISBN 13: 9780387340562
Nuevo
Tapa dura
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled 'Optimizing the Drug-Like Properties of Leads in Drug Discovery,' which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. The volume outlines strategies and methodologies designed to guide pharmaceutical and biotechnology companies through the drug discovery and development process. 524 pp. Englisch. Nº de ref. del artículo: 9780387340562
Gastos de envío:
EUR 23,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 2 disponibles
Imagen de archivo
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects, IV)
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. In. Nº de ref. del artículo: ria9780387340562_new
Gastos de envío:
EUR 13,71
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: Más de 20 disponibles
Imagen del vendedor
"Optimizing the \"Drug-Like\" Properties of Leads in Drug Discovery "
Publicado por
Springer New York, Springer New York, 2006
ISBN 10: 0387340564
ISBN 13: 9780387340562
Nuevo
Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, 'drug-like' properties refer to the molecule's physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development. Nº de ref. del artículo: 9780387340562
Gastos de envío:
EUR 65,86
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 1 disponibles
Imagen del vendedor
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery
Publicado por
Springer, New York, 2006
ISBN 10: 0387340564
ISBN 13: 9780387340562
Antiguo o usado
Tapa dura
Librería: PsychoBabel & Skoob Books, Didcot, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: Very Good. Hardcover (no jacket; printed boards). Includes CD-ROM on inside rear board. Very good condition. Half-title page has partially separated from binding. Boards' leading corners are a little bumped and scuffed. Pages are clear. TA. Used. Nº de ref. del artículo: 510803
Gastos de envío:
EUR 10,87
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 1 disponibles
Imagen de archivo
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects)
Publicado por
Amer Assn of Pharmaceutical, 2006
ISBN 10: 0387340564
ISBN 13: 9780387340562
Nuevo
Tapa dura
Librería: Revaluation Books, Exeter, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: Brand New. 1st hardback/cd-rom edition. 512 pages. 10.00x7.00x1.25 inches. In Stock. Nº de ref. del artículo: x-0387340564
Gastos de envío:
EUR 17,17
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 2 disponibles